Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Gallbladder Adenocarcinoma

Gallbladder Adenocarcinoma

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Gallbladder Adenocarcinoma

2 trials tracked for Gallbladder Adenocarcinoma.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 2
  1. Phase 2 Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma Completed
  2. Phase 2 Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Trastuzumab emtansine and sintilimab combination shows lesion size reduction in HER2-positive metastatic gallbladder adenocarcinoma
Neurology Sys. Review
Trastuzumab emtansine and sintilimab combination shows lesion size reduction in HER2-positive metastatic gallbladder adenocarcinoma New drug combination shows promise for certain gallbladder cancer
This case report and literature review describes a 46-year-old male with HER2-positive metastatic gallbladder adenocarcinoma treated with tr…
A new treatment combination involving trastuzumab emtansine and sintilimab helped shrink tumors in a patient with a specific type of gallbla…
Frontiers Sep 10, 2026
Segment 4b/5 resection versus wedge resection showed no impact on long-term oncological outcomes in gallbladder cancer patients
Drug Pipeline RCT
Segment 4b/5 resection versus wedge resection showed no impact on long-term oncological outcomes in gallbladder cancer patients Surgical removal of specific liver parts did not improve survival or safety for gallbladder cancer patients
This phase 3 randomized controlled trial enrolled 163 patients undergoing surgery for gallbladder cancer after ruling out metastatic or unre…
Doctors compared two ways to remove part of the liver during gallbladder cancer surgery. Patients who had the larger cut stayed in the hospi…
May 1, 2026